Skin Rebirth
⚠️ High Risk
FEI: 3003245145 • Empuriabram • SPAIN
High Risk
FDA Import Risk Assessment
This firm has a significant history of FDA import refusals with notable violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
DRUG GMPS
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the methods used in and controls used for the manufacture, processing, packing, or holding of drugs and other products do not appear to conform to current good manufacturing practices within the meaning of Section 501(a)(2)(B).
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 10/24/2005 | 66VCK99MISCELLANEOUS PATENT MEDICINES, ETC. | 27DRUG GMPS | Cincinnati District Office (CIN-DO) |
| 10/24/2005 | 66VCK99MISCELLANEOUS PATENT MEDICINES, ETC. | 27DRUG GMPS | Cincinnati District Office (CIN-DO) |
| 10/24/2005 | 66VCK99MISCELLANEOUS PATENT MEDICINES, ETC. | 27DRUG GMPS | Cincinnati District Office (CIN-DO) |
| 10/24/2005 | 66VCK99MISCELLANEOUS PATENT MEDICINES, ETC. | 27DRUG GMPS | Cincinnati District Office (CIN-DO) |
| 10/24/2005 | 66VCK99MISCELLANEOUS PATENT MEDICINES, ETC. | 27DRUG GMPS | Cincinnati District Office (CIN-DO) |
| 10/24/2005 | 66VCK99MISCELLANEOUS PATENT MEDICINES, ETC. | 27DRUG GMPS | Cincinnati District Office (CIN-DO) |
| 10/24/2005 | 66VCK99MISCELLANEOUS PATENT MEDICINES, ETC. | 27DRUG GMPS | Cincinnati District Office (CIN-DO) |
| 10/24/2005 | 66VCK99MISCELLANEOUS PATENT MEDICINES, ETC. | 27DRUG GMPS | Cincinnati District Office (CIN-DO) |
| 10/24/2005 | 66VCK99MISCELLANEOUS PATENT MEDICINES, ETC. | 27DRUG GMPS | Cincinnati District Office (CIN-DO) |
| 10/24/2005 | 66VCK99MISCELLANEOUS PATENT MEDICINES, ETC. | 27DRUG GMPS | Cincinnati District Office (CIN-DO) |
| 10/24/2005 | 66VCK99MISCELLANEOUS PATENT MEDICINES, ETC. | 27DRUG GMPS | Cincinnati District Office (CIN-DO) |
| 10/24/2005 | 66VCK99MISCELLANEOUS PATENT MEDICINES, ETC. | 27DRUG GMPS | Cincinnati District Office (CIN-DO) |
| 10/24/2005 | 66VCK99MISCELLANEOUS PATENT MEDICINES, ETC. | 27DRUG GMPS | Cincinnati District Office (CIN-DO) |
| 10/24/2005 | 66VCK99MISCELLANEOUS PATENT MEDICINES, ETC. | 27DRUG GMPS | Cincinnati District Office (CIN-DO) |
| 10/24/2005 | 66VCK99MISCELLANEOUS PATENT MEDICINES, ETC. | 27DRUG GMPS | Cincinnati District Office (CIN-DO) |
| 10/24/2005 | 66VCK99MISCELLANEOUS PATENT MEDICINES, ETC. | 27DRUG GMPS | Cincinnati District Office (CIN-DO) |
| 10/24/2005 | 66VCK99MISCELLANEOUS PATENT MEDICINES, ETC. | 27DRUG GMPS | Cincinnati District Office (CIN-DO) |
| 10/24/2005 | 66VCK99MISCELLANEOUS PATENT MEDICINES, ETC. | 27DRUG GMPS | Cincinnati District Office (CIN-DO) |
| 10/24/2005 | 66VCK99MISCELLANEOUS PATENT MEDICINES, ETC. | 27DRUG GMPS | Cincinnati District Office (CIN-DO) |
| 10/24/2005 | 66VCK99MISCELLANEOUS PATENT MEDICINES, ETC. | 27DRUG GMPS | Cincinnati District Office (CIN-DO) |
| 10/24/2005 | 66VCK99MISCELLANEOUS PATENT MEDICINES, ETC. | 27DRUG GMPS | Cincinnati District Office (CIN-DO) |
| 8/5/2003 | 60QCS46PROCAINE HCL (ANESTHETIC) | 75UNAPPROVED | Cincinnati District Office (CIN-DO) |
Frequently Asked Questions
What is Skin Rebirth's FDA import refusal history?
Skin Rebirth (FEI: 3003245145) has 22 FDA import refusal record(s) in our database, spanning from 8/5/2003 to 10/24/2005.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Skin Rebirth's FEI number is 3003245145.
What types of violations has Skin Rebirth received?
Skin Rebirth has been cited for 2 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Skin Rebirth come from?
All FDA import refusal data for Skin Rebirth is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.